These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Infliximab vs adalimumab for Crohn's disease. Dhillon AS; Harris AW Clin Gastroenterol Hepatol; 2015 Jan; 13(1):210. PubMed ID: 24954114 [No Abstract] [Full Text] [Related]
7. Infliximab vs adalimumab for Crohn's disease: perhaps too early to call it a tie. Dassopoulos T; Sorrentino D Clin Gastroenterol Hepatol; 2014 May; 12(5):818-20. PubMed ID: 24342747 [No Abstract] [Full Text] [Related]
8. Postoperative Crohn's disease: how can we prevent it? Swoger JM; Regueiro M Expert Rev Clin Immunol; 2010 Jul; 6(4):501-4. PubMed ID: 20594119 [No Abstract] [Full Text] [Related]
9. Postoperative infliximab and elemental diet combination in a case with diffuse, extensive jejunoileal Crohn's disease. Matsuda S; Bamba T; Sohma S; Yamamoto T Int J Colorectal Dis; 2014 Feb; 29(2):265-6. PubMed ID: 24150229 [No Abstract] [Full Text] [Related]
10. Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record? Sorrentino D Inflamm Bowel Dis; 2012 Sep; 18(9):1624-5; author reply 1626-7. PubMed ID: 22359378 [No Abstract] [Full Text] [Related]
11. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy. Lichtenstein GR Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959 [No Abstract] [Full Text] [Related]
12. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience. Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869 [TBL] [Abstract][Full Text] [Related]
13. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet. Sorrentino D; Paviotti A Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431 [No Abstract] [Full Text] [Related]
14. [Prevention of post-surgical recurrence of Crohn's disease. A perspective]. Paviotti A; Terrosu G; Avellini C; Girometti R; Sorrentino D Recenti Prog Med; 2009 May; 100(5):233-8. PubMed ID: 19772213 [TBL] [Abstract][Full Text] [Related]
15. Infliximab in Crohn's disease: early and long-term treatment. Armuzzi A; De Pascalis B; Fedeli P; De Vincentis F; Gasbarrini A Dig Liver Dis; 2008 Jul; 40 Suppl 2():S271-9. PubMed ID: 18599000 [TBL] [Abstract][Full Text] [Related]
16. [Biological compounds in the treatment of Crohn's disease]. Dinari G Harefuah; 2001 Apr; 140(4):316-8. PubMed ID: 11303396 [No Abstract] [Full Text] [Related]
17. Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan. Fukushima K; Sugita A; Futami K; Takahashi KI; Motoya S; Kimura H; Yoshikawa S; Kinouchi Y; Iijima H; Endo K; Hibi T; Watanabe M; Sasaki I; Suzuki Y; Surg Today; 2018 Jun; 48(6):584-590. PubMed ID: 29383596 [TBL] [Abstract][Full Text] [Related]
18. Reply: To PMID 24530602. Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1407. PubMed ID: 24614332 [No Abstract] [Full Text] [Related]